# Study of Mepolizumab Safety Syringe in Asthmatics

> **NCT03021304** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Mepolizumab

## Key facts

- **NCT ID:** NCT03021304
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-08-08
- **Final completion:** 2017-08-08
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03021304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03021304, "Study of Mepolizumab Safety Syringe in Asthmatics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03021304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*